8542
K.-i. Fujita et al. / Tetrahedron 66 (2010) 8536e8543
4.3.1. N,N0-Ethane-1,2-diyl N,N0-bis(3,5-dimethoxybenzyloxy) N,N,N0,
N0-tetramethylammonium dibromide (1(G1)). White powder; mp
201.5e202 ꢁC; IR (KBr) 3483, 2976, 2952, 1598, 1350, 1208, 1175,
1154, 1066, 1044, 934, 843 cmꢀ1; 1H NMR (400 MHz; CDCl3/CD3OD)
temperature under an argon atmosphere. The resulting two-phase
mixture was vigorously stirred for 5 h. The reaction mixture was
extracted with toluene (80 mLꢂ3). After removal of the solvent
under reduced pressure, 2(G3) was obtained as a black solid
(1.667 g). The Os content of 2(G3) was determined by ICP-AES after
microwave digestion by the addition of HNO3.
d
¼6.81 (d, J¼2.0 Hz, 4H), 6.60 (t, J¼2.0 Hz, 2H), 4.78 (s, 4H), 4.55 (s,
4H), 3.84 (s, 12H), 3.28 (s, 12H); 13C NMR (100 MHz; CDCl3/CD3OD)
d
¼162.0, 128.9, 111.9, 103.1, 69.1, 57.9, 56.0, 50.7. Anal. Calcd for
C24H38Br2N2O4$0.2H2O: C, 49.53; H, 6.65; N, 4.81; Br, 27.46%.
Found: C, 49.64; H, 6.68; N, 4.83; Br, 27.16%.
4.4.1. Compound (2(G1)). Black powder; mp 203e205 ꢁC; Os con-
tent: 0.36 mmol/g; IR (KBr) 3418, 3000, 2966, 2943, 2841, 1595,
1328, 1207,1157, 1065, 853, 833 cmꢀ1. Anal. Found: C, 41.46; H, 5.71;
N, 3.96%.
4.3.2. N,N0-Ethane-1,2-diyl
N,N0-[3,5-bis(3,5-dimethoxybenzyloxy)-
benzyloxy]N,N,N0,N0-tetramethylammoniumdibromide(1(G2)). White
powder; mp 183e184.5 ꢁC; IR (KBr) 3386, 3002, 2962, 2838, 1597,
4.4.2. Compound (2(G2)). Black powder; mp 79e81 ꢁC; Os content:
0.76 mmol/g; IR (KBr) 3446, 2955, 2938, 2837, 1598, 1205, 1155,
1052, 833 cmꢀ1. Anal. Found: C, 54.39; H, 5.85; N, 2.41%.
1465, 1430, 1298, 1205, 1159, 1052, 834 cmꢀ1 1H NMR (400 MHz;
;
CDCl3)
8H), 6.37 (t, J¼2.2 Hz, 4H), 4.97 (s, 4H), 4.94 (s, 8H), 4.82 (s, 4H), 3.75
(s, 24H), 3.20 (s, 12H); 13C NMR (100 MHz, CDCl3)
138.6, 127.9, 112.1, 105.5, 104.7, 99.9, 70.1, 67.6, 57.9, 55.5, 50.0. Anal.
Calcd for C56H70Br2N2O12: C, 59.89; H, 6.28; N, 2.49; Br, 14.23%.
Found: C, 59.88; H, 6.12; N, 2.41; Br, 13.96%.
d¼6.77 (d, J¼1.8 Hz, 4H), 6.62e6.59 (m, 2H), 6.55 (d, J¼2.2 Hz,
d¼161.0, 160.0
4.4.3. Compound (2(G3)). Black powder; mp 49e51 ꢁC; Os content:
0.22 mmol/g; IR (KBr) 3447, 2961, 2936, 2838, 1457, 1205, 1155,
1052, 832 cmꢀ1. Anal. Found: C, 63.29; H, 5.95; N, 1.21%.
4.4.4. Compound (5). Black powder; mp 76e78 ꢁC; Os content:
0.33 mmol/g; IR (KBr) 3383, 3001, 2936, 2837, 1597, 1456,1373,1323,
1206, 1155, 1051, 835 cmꢀ1. Anal. Found: C, 60.78; H, 5.66; N, 1.09%.
4.3.3. N,N0-Ethane-1,2-diyl N,N0-[3,5-bis[3,5-bis(3,5-dimethoxybenzyl-
oxy)benzyloxy]benzyloxy] N,N,N0,N0-tetramethylammonium dibromide
(1(G3)). White powder; mp 72.5e74.5 ꢁC; IR (KBr) 3356, 3000,
2937, 2838, 1590, 1429, 1300, 1270, 1205, 1150, 1052, 1009,
4.4.5. Compound (6). Black powder; mp 70.5e72.5 ꢁC; Os content:
0.20 mmol/g; IR (KBr) 3399, 2999, 2938, 2839,1597,1458,1342,1323,
1206, 1155, 1051, 837 cmꢀ1. Anal. Found: C, 62.56; H, 5.99; N, 1.08%.
834 cmꢀ1; 1H NMR (400 MHz; CDCl3)
d¼6.71 (d, J¼1.6 Hz, 4H), 6.67
(d, J¼2.0 Hz, 8H), 6.61e6.56 (m, 2H), 6.52 (d, J¼2.0 Hz, 16H), 6.51 (t,
J¼2.0 Hz, 4H), 6.35 (t, J¼2.2 Hz, 8H), 4.90 (s, 24H), 4.86 (s, 4H), 4.67
(s, 4H), 3.72 (s, 48H), 3.10 (s, 12H); 13C NMR (100 MHz; CDCl3)
4.5. Dihydroxylation reaction: typical procedure
d
¼160.9, 160.0, 159.9, 139.1, 138.8, 127.8, 111.9, 106.6, 105.3, 104.7,
101.7, 99.8, 70.0, 67.7, 57.9, 55.4, 49.9. Anal. Calcd for
C120H134Br2N2O28: C, 65.15; H, 6.11; N, 1.27; Br, 7.22%. Found: C,
64.99; H, 5.93; N, 1.22; Br, 7.08%.
To a CH3CN/H2O (4:1, v/v) solution (3.75 mL) of 2(G3) (48.5 mg,
0.01 mmol) were added trans-b-methylstyrene (120.2 mg,
1.017 mmol) and N-methylmorpholine N-oxide (NMO; 141.6 mg,
1.209 mmol) successively at room temperature under an argon
atmosphere. After stirring the resulting mixture for 0.5 h, the
dihydroxylation reaction was completed (monitored by TLC). The
reaction mixture was evaporated and dissolved in a small amount
of acetone. The acetone solution was poured into 6 mL of water to
precipitate 2(G3) as a grayish powder. After centrifugal separation,
the aqueous solution was decanted, and the recovered 2(G3) was
reused for subsequent dihydroxylation reactions.
The decanted aqueous solution was concentrated under reduced
pressure, and was purified with silica gel column chromatography
(hexane/ethyl acetate¼1/1 as an eluent) to obtain 1-phenyl-1,2-
propanediol (133.3 mg, 0.876 mmol) in an 86% yield.
4.3.4. N,N0-Propane-1,2-diyl
N,N0-[3,5-bis[3,5-bis(3,5-dimethoxy-
N,N,N0,N0-tetramethylammonium
benzyloxy)benzyloxy]benzyloxy]
dibromide (3). White powder; mp 71e73 ꢁC; IR (KBr) 3399, 2999,
2936, 2837, 1595, 1458, 1373, 1298, 1206, 1153, 1049, 831, 681 cmꢀ1
1H NMR (400 MHz; CDCl3)
;
d
¼6.78 (d, J¼1.7 Hz, 4H), 6.67 (d,
J¼2.1 Hz, 8H), 6.64e6.62 (m, 2H), 6.54 (d, J¼2.2 Hz, 16H), 6.52
(t, J¼2.0 Hz, 4H), 6.37 (t, J¼2.2 Hz, 8H), 4.95 (s, 8H), 4.92 (s, 16H),
4.64 (s, 4H), 3.74 (s, 52H), 3.05 (s, 12H), 2.46 (s, 2H); 13C NMR
(100 MHz; CDCl3)
d
¼160.9, 160.0, 159.9, 139.1, 138.8, 128.6, 112.0,
106.6, 105.3, 104.5, 101.7, 99.8, 70.1, 70.0, 67.8, 62.4, 55.4, 50.2, 19.1.
Anal. Calcd for C121H136Br2N2O28: C, 65.28; H, 6.16; N,1.26; Br, 7.18%.
Found: C, 65.00; H, 6.18; N, 1.22; Br, 7.08%.
In Tables 2e4, the chemical yields were determined by in-
tegrating 1H NMR absorptions by referring to an internal standard,
which was added to the decanted aqueous solution. The leaching of
osmium in Table 4 was determined by ICP-AES measurement of the
decanted aqueous solution.
4.3.5. N,N0-Butane-1,2-diyl N,N0-[3,5-bis[3,5-bis(3,5-dimethoxybenzyl-
oxy)benzyloxy]benzyloxy] N,N,N0,N0-tetramethylammonium dibromide
(4). White powder; mp 68.5e70.5 ꢁC; IR (KBr) 2995, 2936, 2837,
1595, 1458, 1319, 1206, 1153, 1049, 831, 681 cmꢀ1
;
1H NMR
(400 MHz; CDCl3)
d
¼6.78 (d, J¼1.7 Hz, 4H), 6.66 (d, J¼2.1 Hz, 8H),
6.63e6.60 (m, 2H), 6.53 (d, J¼2.2 Hz,16H), 6.50 (t, J¼2.0 Hz, 4H), 6.35
(t, J¼2.2 Hz, 8H), 4.95 (s, 8H), 4.92 (s, 16H), 4.59 (s, 4H), 3.87 (br s,
4H), 3.72 (s, 48H), 3.00 (s, 12H), 2.07 (s, 4H); 13C NMR (100 MHz;
4.6. Asymmetric dihydroxylation reaction: typical procedure
To a CH3CN/H2O (4:1, v/v) solution (2.5 mL) of 2(G3) (46.6 mg,
0.01 mmol) was added 1,4-bis(9-O-dihydroquininyl)phthalazine
((DHQ)2-PHAL) (8.2 mg, 0.011 mmol). After the reaction mixture
CDCl3)
d
¼161.0, 160.03, 159.95, 139.2, 138.8, 128.8, 112.1, 106.6, 105.3,
104.4,101.7, 99.9, 70.1, 70.0, 67.6, 64.5, 55.4, 49.8, 20.2. Anal. Calcd for
C122H138Br2N2O28$2H2O: C, 64.37; H, 6.29; N, 1.23; Br, 7.02%. Found:
C, 64.33; H, 6.13; N, 1.16; Br, 7.04%.
was stirred for 10 min, trans-b-methylstyrene (118.3 mg,1.00 mmol)
and N-methylmorpholine N-oxide (NMO; 140.5 mg, 1.20 mmol)
were added successively at room temperature under an argon at-
mosphere. After the resulting mixture was stirred for 0.5 h, the
dihydroxylation reaction was completed (monitored by TLC). The
reaction mixture was evaporated and dissolved in a small amount of
acetone. The acetone solution was poured into 6 mL of water to
precipitate 2(G3) and (DHQ)2-PHAL as a grayish powder. After
centrifugal separation, the aqueous solution was decanted, and the
4.4. Preparation of dendritic osmate 2(Gn), 5, and 6: typical
procedure
To a toluene solution (degassed; 80 mL) of 1(G3) (1.547 g,
0.698 mmol), an aqueous solution (degassed; 50 mL) of
K2OsO4$2H2O (256 mg, 0.695 mmol) was added at room